Win 49596-finasteride method of use and compositions
US5175155A · kind A · utility
23Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 7, 1991 |
| Grant date | Dec 29, 1992 |
| Priority date | — |
| Expiry date | Oct 7, 2011 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The method of use of a combination of the antiandrogen (5.alpha.,17.alpha.)-1'-(methylsulfonyl)-1'H-pregn-20-yno[3,2-c]pyrazol-17 -ol (Win 49596) and the 5.alpha.-reductase inhibitor (5.alpha.,17.beta.)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carb oxamide (finasteride) for treating prostate disease in a male mammal and pharmaceutical compositions thereof are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.